Opportunities for Researchers

In addition to encouraging scientific ideas for researchers through investigator-initiated applications and omnibus solicitations, DCCPS develops and participates in NIH funding opportunities aimed at stimulating new directions in specific research to examine, discover, and test methodologies to improve public health. The following are examples of recent funding opportunity announcements to encourage research projects in emerging or priority areas and to support the next generation of cancer researchers.

From DCCPS

  • Exploratory Grants in Cancer Control
  • Modular R01s in Cancer Control and Population Sciences
  • Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
  • Research Opportunities in Established Cancer Epidemiology Cohort Studies
  • Impacts of Climate Change Across the Cancer Control Continuum (R01 Clinical Trial Optional)
  • Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
  • Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
  • Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
  • Pragmatic Trials Across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
  • Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 and R21 Clinical Trials Optional)
  • Limited Competition: Specialized Centers of Excellence on Environmental Health Disparities Research (P50 Clinical Trial Optional)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
  • Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
  • Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 and R21, Clinical Trial Not Allowed)

From NCI

Continue To

Investments in Cancer Control Research